TNF-alpha is an inflammatory cytokine produced by the immune system. Serum TNF-alpha level is elevated in some pathological states such as septic shock, graft rejection, HIV infection, neurodegenerative diseases, rheumatoid arthritis and cancer. Detecting trace amount of TNF-alpha is, also, very important for the understanding of tumor biological processes. Detection of this key biomarker is commonly achieved by use of ELISA or cytofluorimetric based methods. In this study the traditional optical detection was replaced by differential pulse voltammetry (DPV) and an affinity molecule, produced by evolutionary approaches, has been tested as capture bioreceptor. This molecule, namely a combinatorial non-immunoglobulin protein (Affibody (R)) interacts with TNF-alpha selectively and was here tested in a sandwich assay format. Moreover magnetic beads were used as support for bioreceptor immobilization and screen printed carbon electrodes were used as transducers.TNF-alpha calibration curve was performed, obtaining the detection limit of 38 pg/mL, the quantification range of 76-5000 pg/mL and RSD%=7. Preliminary results of serum samples analysis were also reported. (C) 2016 Elsevier B.V. All rights reserved.

Baydemir, G., Bettazzi, F., Palchetti, I., Voccia, D., Strategies for the development of an electrochemical bioassay for TNF-alpha detection by using a non-immunoglobulin bioreceptor, <<TALANTA>>, 2016; 151 (N/A): 141-147-147. [doi:10.1016/j.talanta.2016.01.021] [http://hdl.handle.net/10807/155916]

Strategies for the development of an electrochemical bioassay for TNF-alpha detection by using a non-immunoglobulin bioreceptor

Voccia, Diego
2016

Abstract

TNF-alpha is an inflammatory cytokine produced by the immune system. Serum TNF-alpha level is elevated in some pathological states such as septic shock, graft rejection, HIV infection, neurodegenerative diseases, rheumatoid arthritis and cancer. Detecting trace amount of TNF-alpha is, also, very important for the understanding of tumor biological processes. Detection of this key biomarker is commonly achieved by use of ELISA or cytofluorimetric based methods. In this study the traditional optical detection was replaced by differential pulse voltammetry (DPV) and an affinity molecule, produced by evolutionary approaches, has been tested as capture bioreceptor. This molecule, namely a combinatorial non-immunoglobulin protein (Affibody (R)) interacts with TNF-alpha selectively and was here tested in a sandwich assay format. Moreover magnetic beads were used as support for bioreceptor immobilization and screen printed carbon electrodes were used as transducers.TNF-alpha calibration curve was performed, obtaining the detection limit of 38 pg/mL, the quantification range of 76-5000 pg/mL and RSD%=7. Preliminary results of serum samples analysis were also reported. (C) 2016 Elsevier B.V. All rights reserved.
2016
Inglese
Baydemir, G., Bettazzi, F., Palchetti, I., Voccia, D., Strategies for the development of an electrochemical bioassay for TNF-alpha detection by using a non-immunoglobulin bioreceptor, <<TALANTA>>, 2016; 151 (N/A): 141-147-147. [doi:10.1016/j.talanta.2016.01.021] [http://hdl.handle.net/10807/155916]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/155916
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 46
social impact